Members of PATH’s Chinese Leadership Council understand the importance and benefits of philanthropy. They work side-by-side with our Development team to mobilize resources and raise our profile within the Chinese-American community and among supporters in China, where PATH has deep roots.
Yi Ping (Y.P.) Chan, MSEE, MBA
Y.P. Chan is a principal at Chanden Inc., an investment and businesses advising firm. He specializes in strategy, operations, business/financial modeling and infrastructure building, and has more than 20 years’ experience in business turnaround and restructuring, entrepreneurship, investment, executive education, and joint venture and acquisitions in the United States, China, Japan and Korea.
In addition to PATH’s Chinese Leadership Council, Y.P. serves on the advisory board of the School of Business at the University of Washington, Bothell, and the Greater Seattle Chinese Chamber of Commerce. He is a visiting executive lecturer at the University of Virginia’s Darden School; a part-time professor at the Southwest University of Science and Technology in China; and a lecturer on entrepreneurship and venture investment at Shanghai University.
Y.P. earned a bachelor’s degree in electrical engineering (magna cum laude) from New York University; and, with sponsorship from IBM, earned master’s degrees in both business administration and electrical engineering from Columbia University.
“Global Health is probably one of the best way to fight inequality in a society and have the highest return in term of improving the quality of life.”
Steve Chen, MBA
Steve Chen is a partner in Skyline Investment Fund LP, which manages $200 million in commercial real estate investments in the United States. He is also cofounder and director of the Pathway Foundation, which promotes civic engagement within the Chinese-American community.
Steve started his career as an information technology consultant; before he became involved with commercial real estate, he spent 15 years conducting business with China for a consulting firm he founded.
Steve earned a master’s degree in engineering from Utah State University. He also holds and a master’s degree in science in economics and a bachelor’s degree in engineering from Tsinghua University in Beijing.
“I believe that Chinese Americans should become involved in philanthropy and civic engagement as part of our civic lives. PATH—which started 40 years ago with a project in China—offers a platform for me to fulfill this goal, and encourage others to also become involved.”
Conrad Lee, MBA
Conrad Lee is Bellevue, Washington’s longest-serving City Council member and was the council’s first minority member. He was also the first person of Asian descent to serve as Bellevue’s mayor, a post he held from 2012-2013. He is cofounder of the Pathway Foundation, which promotes civic engagement within the Chinese-American community.
Conrad retired after a career that included being regional administrator of the United States Small Business Administration (appointed by President George W. Bush); an engineer for Boeing and Seattle Solid Waste Utility; a stockbroker; an international business consultant; and a real estate investor and manager.
Conrad served on the board of directors and advisory council of the National League of Cities, and he is past president of the NLC’s Asian Pacific American Municipal Officials. He is also past president of the Seattle Chinese Garden Society, and he chaired the 1992 Washington State Summer Games.
Born in China and raised in Hong Kong, Conrad holds a bachelor’s degree in engineering from the University of Michigan and a master's degree in business administration from the Foster School of Business at the University of Washington.
“The United States and China have the most influence in global health—a top priority for human wellbeing. I choose to invest in PATH because as a socially and politically engaged Chinese-American, I can be a bridge in this important challenge.”
Yehong Zhang, PhD, MBA
Yehong Zhang is the CEO of Luye Pharmaceutical Group (International). Prior to joining Luye in 2016, Yehong was Aetna’s general manager for Greater China, and before that he was CEO of Simcere MSD Pharmaceutical Co. Ltd, a joint venture between Simcere, a leading China-based pharmaceutical manufacturer, and Merck & Co. Previously, as Simcere’s president, he was instrumental in driving strategic partnerships with large multinational pharmaceutical companies to serve China’s rapidly expanding health care needs.
Prior to Simcere, Yehong was a practice leader for McKinsey & Co.’s health care consultancy efforts in China, where he advised local health care companies and worked closely with government stakeholders. Earlier, he was the China president for Merck and held a similar role for IMS Health, a leading health care information, services, and technology company.
A native of China, Yehong was educated in the United States. He holds a doctorate in engineering from the University of Pennsylvania, an MBA from the Wharton School, and an undergraduate degree from Harvard University.